Cloverfields Capital Group, LP
- SEC CIK
- 0001819581
- Latest filing
- Aug 13, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by Cloverfields Capital Group, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −8,765−100.0% | Sold out | Holders |
| Q4 2025 | 8,765 | $5.08M | 1.6% | −411−4.5% | Reduced | Holders |
| Q3 2025 | 9,176 | $4.45M | 1.4% | −117−1.3% | Reduced | Holders |
| Q2 2025 | 9,293 | $3.77M | 1.1% | −180−1.9% | Reduced | Holders |
| Q1 2025 | 9,473 | $4.71M | 1.6% | −383−3.9% | Reduced | Holders |
| Q4 2024 | 9,856 | $5.13M | 1.6% | +20.0% | Added | Holders |
| Q3 2024 | 9,854 | $6.10M | 2.0% | −822−7.7% | Reduced | Holders |
| Q2 2024 | 10,676 | $5.90M | 2.0% | −96−0.9% | Reduced | Holders |
| Q1 2024 | 10,772 | $6.26M | 2.1% | +581+5.7% | Added | Holders |
| Q4 2023 | 10,191 | $5.41M | 2.1% | +10,191 | New | Holders |